BioCanRx Public Forum

Join us on March 28th for a free Public Forum on cancer immunotherapy in Canada!

Register here

Immunotherapy, treatment which trains the immune system to fight disease, prevents and treats a range of cancers, and increasingly being considered for autoimmune diseases.

On March 28, 2026, BioCanRx will host five experts at Simon Fraser University's Morris J. Wosk Centre for Dialogue to discuss immunotherapy treatments for cancer and what they mean for Canadians. Internationally renowned health policy consultant, Louise Binder of Save Your Skin Foundation, will moderate discussions with Scientific Director, Dr. John Bell (Order of Canada recipient 2025), Dr. Robert Holt and Dr. Brad Nelson of BC Cancer, Dr. Hannah Cherniawsky of the Leukemia/Bone Marrow Transplant Program, and PhD Candidate Lorenzo Lindo to talk about how immunotherapy can benefit Canadians, how immunotherapies are made and used in Canada, and how immunotherapies change the future for Canadians living with cancer – and potentially, many other diseases.

This event is free and open to the public. Patients, caregivers, patient advocates, medical professionals, and any other interested individuals are encouraged to attend.

  • 10x Genomics
  • adMare BioInnovations
  • Akoya Biosciences
  • BD Biosciences
  • bioMérieux
  • Centre C3i
  • Canadian Advanced Therapies Training Institute
  • Cencora World Courier
  • Cytek Biosciences
  • GSK
  • Immudex
  • Kite Gilead
  • Miltenyi
  • OBIO
  • Roche